Lot documentation is pending
We show no result for this exact configuration while its lot-specific report is unavailable.
Browse the COA library
In stock
Purity:99.89% by HPLC
Package image for the selected configuration.
KLOW
An 80 mg blend containing GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, and KPV 10 mg.
Available to verified research accountsExact-SKU documentationLaboratory research use only
The U.S. Food and Drug Administration has not evaluated statements on this site. Stack Research products are not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Lab results for the selected configuration
The published laboratory report covers this exact lot.
- Exact SKU
- STK-KBT80
- Lot
- 8243101
- Laboratory
- Accumark Labs
- Report ID
- JZ2Y-AD4P
- Sample received
- 2026-08-10
- Published
- August 13, 2026
IdentityConforms
HPLC purity99.89% by HPLC
Measured content72.02 mg measured
Bacterial endotoxinPass
SterilityNot detected
Read the complete laboratory report
Open full report
Open the PDF to read every page in the lot-specific report.
Documentation is pending for this exact SKU
We show no purity, identity, content, or contaminant result until a lot-specific report is available.
About KLOW
KLOW combines four listed components in one fixed catalog configuration. The selected papers discuss GHK-Cu, BPC-157, thymosin beta 4, and KPV separately; none evaluates KLOW as a formulation.
The cited papers discuss named components, not this combined Stack Research formulation. They do not establish the blend's identity, component interaction, stability, purity, performance, or suitability. For lawful in-vitro laboratory or analytical research only. Not for human or veterinary use.
Configuration and documentation
The configuration selected above controls the exact SKU, package image, and lot report shown on this page.
Research-use boundary
This page does not provide dosing, administration, treatment, diagnostic, or human-outcome guidance.
Product specifications
- Available configurations
- 80 mg total
- Physical form
- Lyophilized four-component blend
- Composition
- GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg
- Molecular formula
- Multi-component blend
- CAS number
- See individual components
- Molecular weight
- See individual components
- Documentation
- Lot-specific COA published for this exact SKU.
Research & literature
Researchers studied the listed components separately; no cited paper evaluates the combined Stack Research formulation.
A paper's findings do not establish the identity, purity, safety, or intended use of this product.
Search PubMed for KLOW (opens in a new tab)- GHK-Cu Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Pickart L et al. · International Journal of Molecular Sciences · 2018 PMID: 29986520 (opens in a new tab)
- BPC-157 Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Gwyer D et al. · Cell and Tissue Research · 2019 PMID: 30915550 (opens in a new tab)
- Thymosin beta 4 Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Goldstein AL et al. · Expert Opinion on Biological Therapy · 2012 PMID: 22074294 (opens in a new tab)
- KPV Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin. Pawar K et al. · Journal of Pharmaceutical Sciences · 2017 PMID: 28343991 (opens in a new tab)
Mechanism & research background
The selected papers discuss GHK-Cu, BPC-157, thymosin beta 4, and KPV separately. None studies KLOW as a combined formulation or establishes how its components interact.
Researchers studied the listed components separately; no cited paper evaluates the combined Stack Research formulation.
Researchers should read each linked paper for its model, methods, and limits. The cited literature does not supply instructions for this product.
Frequently asked questions
Which components are listed in KLOW?
The managed catalog record lists GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, and KPV 10 mg, for 80 mg total.
Has the full KLOW blend been studied in the cited papers?
No. The sources discuss components separately and cannot establish combined interaction, stability, purity, performance, or suitability.
Is a lot report available for the selected configuration?
A current lot report covers exact SKU STK-KBT80, lot 8243101, from Accumark Labs.
Does the selected configuration control the report shown?
Yes. Choosing a configuration updates every SKU-specific field and its linked lot report as one set.
Do the cited papers verify this vial?
No. The papers describe independent research. The lab-results section above contains the lot-specific evidence for this Stack Research product.
Do the studies cover the full KLOW formulation?
Researchers studied the listed components separately; no cited paper evaluates the combined Stack Research formulation.
Can this page guide human or veterinary use?
No. Stack Research supplies this product for laboratory research only. This page provides no dosing, administration, treatment, or diagnostic guidance.
Can researchers open the original sources?
Yes. Each citation opens its PubMed record. The search link above opens the complete product-specific query.
More to explore
Browse other products currently listed in the Stack Research catalog.
C-AMYLIN / G1-S
Research peptide blends · 5 mg + 5 mg View product
BPC-157 / TB-500
Research peptide blends · 5 mg + 5 mg / 10 mg + 10 mg View product
CJC-1295 no DAC / Ipamorelin
Research peptide blends · 5 mg + 5 mg View product
GLOW 70
Research peptide blends · 70 mg total View product
GLP-1 (SE)
Research peptides · 5 mg / 10 mg View product
GLP-2 (TZ)
Research peptides · 10 mg / 30 mg View product
GLP-3 (RT)
Research peptides · 10 mg / 30 mg View product
BPC-157
Research peptides · 5 mg / 10 mg View product
Need documentation for KLOW?
Send the exact SKU and lot so support can trace the applicable product record.